Marathon Asset Management (UK)’s Pfizer PFE Stock Holding History

Marathon Asset Management (UK)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,258,190	Closed	-$67.3M	–	81
2015 Q3	$67.3M	Buy	2,258,190 +12,185	+0.5%	+$391K	1.62%	21
2015 Q2	$71.4M	Sell	2,246,005 -55,097	-2%	-$1.8M	1.63%	27
2015 Q1	$76M	Sell	2,301,102 -27,221	-1%	-$865K	1.84%	24
2014 Q4	$68.8M	Sell	2,328,323 -8,722	-0.4%	-$250K	1.65%	27
2014 Q3	$65.6M	Buy	2,337,045 +1,200,177	+106%	+$33.7M	1.6%	28
2014 Q2	$32M	Sell	1,136,868 -693,039	-38%	-$19.8M	0.79%	46
2014 Q1	$55.8M	Buy	1,829,907 +273,682	+18%	+$8.16M	1.43%	30
2013 Q4	$45.2M	Sell	1,556,225 -1,145,562	-42%	-$33.3M	1.11%	33
2013 Q3	$73.6M	Buy	2,701,787 +281,073	+12%	+$7.65M	1.79%	23
2013 Q2	$63.8M	Buy	+2,420,714	New	+$66.9M	1.52%	29

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marathon Asset Management (UK)'s PFE Position: Q4 2015 in Review

Marathon Asset Management (UK) sold out of Pfizer (PFE) in Q4 2015, closing a stake of 2,258,190 shares — an estimated $67.3M sold.

Marathon Asset Management (UK) first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $76M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Marathon Asset Management (UK) reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
Marathon Asset Management (UK) sold 2,258,190 Pfizer shares in Q4 2015, an estimated $67.3M.
Marathon Asset Management (UK) first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
Marathon Asset Management (UK)'s Pfizer position peaked at $76M in Q1 2015.
1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Marathon Asset Management (UK)'s 13F filing for Q4 2015, filed 25 Jan 2016.